Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Vyera Pharmaceuticals revenue
Vyera Pharmaceuticals's revenue is $5.0 million.
What is Vyera Pharmaceuticals's revenue?
- Vyera Pharmaceuticals has 175 employees, and the revenue per employee ratio is $28,571.
- Vyera Pharmaceuticals peak revenue was $5.0M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Vyera Pharmaceuticals financing
Vyera Pharmaceuticals received early financing of $90.0M on 2015-08-10.
| Series | Round size | Date |
|---|---|---|
| Series A | $90M | 08/2015 |
Vyera Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Martin Shkreli | Series A |
Vyera Pharmaceuticals competitors
Vyera Pharmaceuticals's top competitor, Merck, earned an annual revenue of $64.2B.
Vyera Pharmaceuticals's smallest competitor is Gemphire Therapeutics with revenue of $2.6M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Thar Pharmaceuticals | $65,146 | $4.0M | 2 | - |
| Imprimis Pharmaceuticals | $62,221 | $48.9M | 143 | - |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 271 |
| Acura Pharmaceuticals, Inc. | $82,668 | $75.0M | 12 | - |
| Merck | $90,328 | $64.2B | 74,000 | 1,400 |
| Harmony Biosciences | $67,511 | $714.7M | 214 | 40 |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | 1 |
| Regeneron | $85,589 | $14.2B | 9,123 | 265 |
| bluebird bio | $98,505 | $3.7M | 518 | 6 |
| Iovance Biotherapeutics | $101,673 | $164.1M | 319 | 24 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Vyera Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Vyera Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Vyera Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Vyera Pharmaceuticals. The data presented on this page does not represent the view of Vyera Pharmaceuticals and its employees or that of Zippia.
Vyera Pharmaceuticals may also be known as or be related to Vyera Pharmaceuticals, Vyera Pharmaceuticals LLC, Vyera Pharmaceuticals, LLC and Vyera Pharmaceuticals, Llc.